Chronic spontaneous urticaria treated with bloodletting therapy and auricular point sticking on the base of xuanfu theory: a randomized controlled trial.
10.13703/j.0255-2930.20210719-0005
- Author:
Yan-Jun WANG
1
;
Yu SHI
1
;
Hong-Kun LI
1
;
Bin SUN
1
;
Wei-Hua XUE
1
;
Huan-Qiang LIU
2
Author Information
1. Department of Acupuncture-Moxibustion, First Affiliated Hospital of Hebei University of TCM, Shijiazhuang 050011, China.
2. Department of Dematology, First Affiliated Hospital of Hebei University of TCM, Shijiazhuang 050011, China.
- Publication Type:Randomized Controlled Trial
- Keywords:
auricular points;
bloodletting;
chronic spontaneous urticaria;
recurrence rate;
xuanfu theory
- MeSH:
Acupuncture Points;
Acupuncture Therapy;
Acupuncture, Ear;
Bloodletting;
Chronic Urticaria;
Humans;
Quality of Life;
Treatment Outcome
- From:
Chinese Acupuncture & Moxibustion
2022;42(2):157-161
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To compare the clinical therapeutic effect and the impacts on recurrence rate on chronic spontaneous urticaria (CSU) between the combined treatment of bloodletting therapy and auricular point sticking on the base of xuanfu theory and the oral solution of levocetirizine hydrochloride.
METHODS:A total of 86 patients with CSU were randomized into an observation group (43 cases, 1 case dropped off) and a control group (43 cases, 3 cases dropped off). In the observation group, bloodletting therapy at Dazhui (GV 14), Feishu (BL 13), Geshu (BL 17) and Pishu (BL 20) was combined with auricular point sticking at lung (CO14), kidney (CO10), shenmen (TF4) and heart (CO15), etc. This combined treatment was given once every two days. In the control group, the oral solution of levocetirizine hydrochloride was prescribed, 10 mL each time, once daily. The treatment lasted for 4 weeks in the two groups. Before and after treatment, urticaria activity score 7 (UAS7), the score of dermatology life quality index (DLQI) and the levels of serum immune globulin E (IgE), interleukin 4 (IL-4) and interferon γ (IFN-γ) were compared in the patients between the two groups. The clinical therapeutic effect was evaluated in patients of the two groups and the recurrence rate was followed up 4, 8 and 12 weeks after treatment separately.
RESULTS:After treatment, the scores of UAS7 and DLQI, as well as the levels of serum IgE and IL-4 were all reduced as compared with those before treatment in the two groups (P<0.05), and the level of serum IFN-γ was increased (P<0.05). The total effective rate was 83.3% (35/42) in the observation group and was 85.0% (34/40) in the control group. There was no statistical significance for the difference in the clinical therapeutic effect between the two groups (P>0.05). Eight and 12 weeks after treatment, the recurrence rates were 21.1% (4/19) and 26.3% (5/19) in the observation group, lower than 55.0% (11/20) and 65.0% (13/20) in the control group, respectively (P<0.05).
CONCLUSION:The combined therapy of bloodletting and auricular point sticking on the base of xuanfu theory relieves the clinical symptoms, regulates the levels of serum IgE, IL-4 and IFN-γ and improves the quality of life in the patients with CSU. The clinical therapeutic effect of this combined treatment is similar to the oral solution of levocetirizine hydrochloride. But, the recurrence rate of the combined treatment of bloodletting and auricular point sticking is lower and its long-term curative effect is better.
